DLD Asset Management LP acquired a new stake in Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 10,000 shares of the company’s stock, valued at approximately $223,000. DLD Asset Management LP owned about […]
Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at Truist Financial in a report released on Thursday, Benzinga reports. They currently have a $150.00 target price on the stock. Truist Financial’s target price suggests a potential upside of 233.70% from the stock’s current price. PRAX has been […]
Praxis Precision Medicines' (PRAX) "Buy" Rating Reaffirmed at HC Wainwright dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Praxis Precision Medicines (NASDAQ:PRAX) versus LifeVantage (NASDAQ:LFVN) Head-To-Head Review themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Praxis Precision Medicines (NASDAQ:PRAX) Now Covered by Analysts at Robert W. Baird theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.